Preview Mode Links will not work in preview mode

This Week in Cardiology

Jun 25, 2021

Myocarditis and the COVID vaccine, lipid lowering guidelines, financial toxicity, and deprescribing statins are the topics covered by John Mandrola, MD, in this week’s podcast.


Varied COVID Vaccination Rates May Lead to 'Two Americas'

Nearly All COVID Deaths in US Are Now Among Unvaccinated

2 - COVID Vaccine Myocarditis

FDA to Add Myocarditis Warning to mRNA COVID-19 Vaccines

3 – Lipid Guidelines

Clinicians Slow to Implement Lipid-Lowering Guidelines: GOULD Registry

- Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US

4 - Financial Toxicity

Financial Burden Higher With CVD Than Cancer

- Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States

5 - Deprescribing Statins

Stopping Statins Linked to Death, CV Events in Elderly

- Cardiovascular Outcomes and Mortality Associated With Discontinuing Statins in Older Patients Receiving Polypharmacy

- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

- Rosuvastatin in Older Patients with Systolic Heart Failure

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact